VESPA Trial: Endovenous laser treatment versus crossectomy of the small saphenous vein.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON20493

Enrollment

180

Registered

2008-11-24

Start date

2008-11-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insufficienct small saphenous vein

Interventions

Endovenous laser treatment (EVLT) Ligation of saphenopopliteal junction

Eligibility

Inclusion criteria

Inclusion criteria: 1. Insufficiency of the small saphenous vein CEAP 2 to 6 2. Age > 18 years old 3. Comprehension of the dutch language 4. Treatment of a least 10 cm 5. Informed consent

Exclusion criteria

Exclusion criteria: 1. Diameter less than 2 mm 2. Simultaneous insufficiency of the large saphenous vein 3. Arterial insufficiency 4. Pregnancy 5. Recurrent insufficiency of the small saphenous vein 6. Spiral shape of the small saphenous vein

Design outcomes

Primary

Measure	Time frame
- Insufficiency after 6 weeks (therapyfailure) - Insufficiency after 1 year (recurrence)	—

Secondary

Measure	Time frame
- Quality of life - Morbidity - Cosmetic results - Duration of treatment - Resumption of work.	—

Contacts

Public ContactA.C. Ham, van der

Sint Franciscus Gasthuis (SFG) Secr. Heelkunde

a.vanderham@sfg.nl+31 (0)10 4616161

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)